Skip to main content

Table 3 Trend test for lung cancer stage of presentation by age, sex, smoking-related histology (N = 2,351)

From: Race, insurance type, and stage of presentation among lung cancer patients

Patient characteristics

Stage

P-for-trend

I

II

III

IV

Unadjusted

Adjusted model 1†¥

Adjusted model 2§₰

 

n (%)

n (%)

n (%)

n (%)

   

Males (n = 1,472)

<0.0001

<0.0001

0.0005

 White

268 (72)

119 (78)

251 (64)

343 (61)

 AA

102 (28)

33 (22)

139 (36)

217 (39)

Females (n = 879)

0.0009

0.0010

0.0030

 White

199 (80)

72 (82)

157 (73)

225 (69)

 AA

50 (20)

16 (18)

57 (27)

103 (31)

Age < 65 (n = 1,008)

0.0040

0.0147

0.0140

 White

142 (67)

73 (78)

176 (63)

247 (58)

 AA

69 (33)

21 (22)

104 (37)

176 (42)

Age ≥ 65 (n = 1,343)

<0.0001

0.0001

0.0001

 White

325 (80)

118 (81)

232 (72)

321 (69)

 AA

83 (20)

28 (19)

92 (28)

144 (31)

Higher smoking risk (n = 978)˄

0.0013

0.0011

0.0015

 White

217 (79)

98 (83)

181 (68)

222 (70)

 AA

58 (21)

20 (17)

85 (32)

97 (30)

Lower smoking risk (n = 1,373)˅

<0.0001

0.0001

0.0011

 White

250 (73)

93 (76)

227 (67)

346 (61)

 AA

94 (27)

29 (24)

111 (33)

223 (39)

   
  1. ˄Squamous cell carcinoma, small cell lung carcinoma (SCLC).
  2. ˅Adenocarcinoma, large cell neuroendocrine carcinoma (LCNEC), bronchoalveolar, non-small-cell lung carcinoma not otherwise specified (NSCLC NOS), other histology. AA = African-American
  3. Exact Cochran-Armitage trend test.
  4. §Likelihood ratio trend test.
  5. ¥Adjusted for sex and smoking-related histology, unless a stratifying variable.
  6. Adjusted for age (continuous), sex and smoking-related histology, unless a stratifying variable.